Impact of a Multisystemic Ultrasound Protocol in Patients of Polyvalent Intensive Care Units

April 15, 2022 updated by: Julio Pontet, Asociacion Española Primera en Salud

Impact of a Multisystemic Ultrasound Protocol in Patients of Polyvalent Intensive Care Units. Multicenter Controlled Study

Ultrasound is a widely used tool for clinicians to manage severe acute patients, seeking to improve the limitations of traditional physical examination and special studies that require patient transfers and can be harmful. This study aims to determine that a pre-established protocol of multiorganic point-of-care ultrasound can be beneficial performed systematically in a critical care patient, improving the diagnosis, detecting hidden anomalies, generating changes in therapy and guiding interventions. A multicenter, randomized controlled clinical trial, against a conventional therapy group is designed. The study group underwent an ultrasound protocol at the entrance of an ICU, of optic, pulmonary, cardiac, abdominal and guide of interventions.

Study Overview

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montevideo, Uruguay, 14002
        • UCI Hospital Pasteur y Asociacion Española

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

• Admitted to the ICU with the requirement of Ventilatory Mechanical Assistance, and admitted for trauma, sepsis, shock of any cause, and postoperative major surgery.

Exclusion Criteria:

  • More than 12 hours of previous hospitalization.
  • Those who refuse to enter the protocol.
  • Those considered by the treating team to be out of recovery possibilities or to enter to support Organ donation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: POCUS protocol group

POCUS protocol group

It will be submitted to an ultrasound protocol which consists in performing the following ultrasound studies in each patient:

Measurement of the diameter of the optic nerve. Neck. Pulmonary ultrasound (LUS score). Echocardiogram (function and volemia). Abdomen. Femoral vascular package. Eco-guided interventionism. Central venous accesses (controlling positioning with saline injection under ultrasound), arterial, pleural or abdominal drainage and percutaneous tracheotomy will be performed under ultrasound.

The findings of multiorgan ultrasound can modify diagnoses and treatments and immediate interventions (eg volume loading with saline solution, pleural or pericardial drainage, initiation of diuretics, increase in positive end expiratory pressure, etc.).

This protocol is performed in the first 24 h of admission to the Intensive Care Unit (ICU) and is repeated at 24 h.

ACTIVE_COMPARATOR: Control group
The usual handling will be followed. The studies will only be performed if the medical team-treating team considers it, requesting a radiologist specialist the same, as is done routinely.
Routine protocol of the treating team is followed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in diagnosis and treatment by point of care ultrasound
Time Frame: Up to 7 days

REGISTER OF (In terms of frequency):

IN DIAGNOSIS:

  • Does not modify the initial diagnosis but confirms it
  • Induces a change in initial diagnosis
  • Discover an unknown initial diagnosis
  • Does not modify the initial diagnosis, does not discard or confirm anything and does not change the treatment that is done.
  • Induces a wrong diagnosis and leads to an error.

IN TREATMENT:

  • Determines the performance of an urgent interventional diagnostic maneuver
  • Determines the performance of an urgent medical or pharmacological therapeutic maneuver of the ICU.
  • Determines the performance of an urgent interventional or surgical therapeutic maneuver
Up to 7 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Definitive diagnosis
Time Frame: Up to 7 days
Delay in performing definitive diagnosis (hours)
Up to 7 days
ICU extra requirements
Time Frame: Up to 7 days
Requests for imaging studies (Number per patient)
Up to 7 days
Interventions
Time Frame: Up to 7 days
Number and type of procedures or interventions performed on the patient (Number per patient)
Up to 7 days
Delay times
Time Frame: Up to 7 days
Delay between the treatment decision and its actual completion (eg pleural drainage) (in hours)
Up to 7 days
Duration of mechanical ventilation
Time Frame: Up to 30 days
Time of invasive mechanical ventilation (days)
Up to 30 days
ICU stay
Time Frame: Up to 30 days
Internment time in ICU (days)
Up to 30 days
Mortality
Time Frame: Up to 30 days
Death rate (percentage)
Up to 30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 1, 2016

Primary Completion (ACTUAL)

May 31, 2017

Study Completion (ACTUAL)

May 31, 2017

Study Registration Dates

First Submitted

March 14, 2017

First Submitted That Met QC Criteria

July 30, 2018

First Posted (ACTUAL)

July 31, 2018

Study Record Updates

Last Update Posted (ACTUAL)

April 19, 2022

Last Update Submitted That Met QC Criteria

April 15, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Clinical and variable data of multiorganic focal ultrasonography

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Point of Care Ultrasound

Clinical Trials on POCUS protocol group

Subscribe